Who is sponsoring NCT07183670?

NCT07183670 is sponsored by Hongying Jiang, MD.

What drugs are being tested in NCT07183670?

Interventions in NCT07183670: decannulation protocol.

What condition does NCT07183670 study?

NCT07183670 studies Prolonged Disorders of Consciousness, Tracheostomy.

Is NCT07183670 still recruiting?

NCT07183670 is currently enrolling by invitation. Last updated 24 February 2026.

Last reviewed 2026-02-24 · How we verify

NCT07183670: STEP-DoC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Standardized Tracheostomy Decannulation Protocol for Patients With Prolonged Disorders of Consciousness

ENROLLING BY INVITATION Last updated 24 February 2026

What this trial tests

trial testing decannulation protocol in Prolonged Disorders of Consciousness in 300 participants. Enrolling by invitation.

Timeline

1 February 2026

Primary endpoint
1 February 2027

1 May 2027

Quick facts

Lead sponsor	Hongying Jiang, MD
Status	ENROLLING BY INVITATION
Study type	OBSERVATIONAL
Enrollment	300
Start date	1 February 2026
Primary completion	1 February 2027
Estimated completion	1 May 2027
Sites	2 locations across China

Drugs / interventions tested

decannulation protocol

Conditions studied

Prolonged Disorders of Consciousness — all drugs for Prolonged Disorders of Consciousness →
Tracheostomy — all drugs for Tracheostomy →

Sponsor

Hongying Jiang, MD

Who can join

Adults 18 to 80, any sex, with Prolonged Disorders of Consciousness or Tracheostomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the feasibility of a standardized tracheostomy decannulation protocol for patients with prolonged Disorders of Consciousness (pDoC) in rehabilitation hospitals.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Prolonged Disorders of Consciousness

Currently open trials in the same condition.

NCT06473285 — Effects of Esketamine on Consciousness-related Brain Network Characteristics in Patients With Prolonged Disorders of Con · NA · recruiting

Other Hongying Jiang, MD trials

Trials by the same sponsor.

NCT07521540 — Integrated Rehabilitation in HDU for Post-Intensive Care SyndromeLiberation in Patients With PICS · NA · not yet recruiting
NCT07435727 — Comparison of Speaking Valve Trial and Capping Trial for Tracheostomy Decannulation in Stroke Patients · NA · not yet recruiting
NCT07173634 — Speaking Valve Trial vs. Capping Trial for Tracheostomy Decannulation in Prolonged Disorders of Consciousness · NA · enrolling by invitation
NCT07317791 — Cough Flow as a Criterion Decannulation Threshold in Prolonged Tracheostomy Patients · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07183670 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hongying Jiang, MD
Last refreshed: 24 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07183670.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing